The short version
- In the STEP 1 extension, people regained about two-thirds of their lost weight within a year of stopping.
- Tirzepatide withdrawal in SURMOUNT-4 showed the same direction of travel.
- Appetite returns before the weight does, which is the window that decides the outcome.
- If money is the reason, stepping down beats stopping dead.
Most Nigerians on these medicines will stop at some point, usually because of cost rather than a clinical decision. What happens next is well documented and rarely discussed by sellers, for obvious reasons.
The evidence
The STEP 1 trial extension followed participants after semaglutide was withdrawn. One year later they had regained roughly two-thirds of the weight they had lost, and much of the improvement in cardiometabolic markers had reversed with it. SURMOUNT-4 tested the same question for tirzepatide and found substantial regain after switching to placebo.
This is not a failure of the medicine. It is what the medicine is: a treatment that works while it is being taken, like blood pressure medication. The difference is that nobody expects their blood pressure to stay fixed after they stop taking amlodipine.
Why it comes back so fast
These drugs suppress appetite centrally and slow gastric emptying. Remove them and both effects unwind within weeks. What people describe is the return of "food noise", the constant low-level awareness of food that had gone quiet.
Add the metabolic adaptation that follows any substantial weight loss, where the body burns slightly less at rest than before, and the odds tilt toward regain unless something replaces the drug's effect.
The window that matters is the first two months after stopping. Appetite returns before the weight does. What you build in that window, in habits and in muscle, decides how much comes back.
If you are stopping because of cost
Consider these before stopping entirely, and discuss them with your doctor.
- Step down rather than stop. A lower dose costs less and keeps some effect. Dropping from 10 mg to 5 mg of tirzepatide saves ₦130,000 a pen at our current prices.
- Switch rather than stop. Semaglutide costs less per pen than tirzepatide.
- Stretch the ladder, not the pen. Staying longer at a dose is reasonable. Skipping weeks to make a pen last is not, because you get the side effects without steady benefit.
If you are stopping by choice
- Decide the date in advance, rather than running out and stopping by accident.
- Get the protein and training habit in place first, while the medicine is still doing the appetite work for you. Muscle is your defence against regain.
- Weigh weekly, not daily, and set a line that triggers a conversation with your doctor, for example five percent back.
- Expect the appetite, plan the portions. Serve in the kitchen rather than family style, and keep the meal structure you built.
- Do not stop abruptly if you have type 2 diabetes without speaking to your doctor about how your blood sugar will be managed instead.
The honest framing before you start
If you can only fund six months, plan for what happens in month seven before you buy the first pen. Six months of treatment followed by a full return to old habits gets you a temporary result and a permanent bill. Six months used to build eating, protein and training habits gives you something to hold onto afterward.
Our guide to expected weight loss covers the trial averages and the spread behind them.
Thinking About Stopping?
If cost is the reason, ask us about lower-dose options before you stop entirely. Clinical decisions belong with your doctor.
PCN-licensed pharmacy · UK-sourced from authorised distributors · Every order reviewed by a registered pharmacist
Message Us on WhatsApp